Phase II Study of SCH66336, A Farnesyltransferase Inhibitor in Chronic Myelogenous Leukemia (CML)

Clinical trial NCT00038597 · COMPLETED

Trial details

NCT number: NCT00038597
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelogenous Leukemia, Chronic

Start date: 2001-04-30
Primary completion: 2004-05-07
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.